Clinical application of metagenomic next-generation sequencing in the diagnosis of severe pneumonia pathogens
Frontiers in Cellular and Infection Microbiology · 06.11.2025 · 15
DOI: 10.3389/fcimb.2025.1661213 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 06.11.2025. Verfasst von Raojuan Huang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Renmin Hospital of Wuhan University, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: High-Throughput Nucleotide Sequencing, Metagenomics, Pneumonia, Bacteria. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Severe pneumonia is a significant cause of mortality among ICU patients. Metagenomic next-generation sequencing (mNGS) is an advanced, comprehensive, unbiased diagnostic tool for pathogen identification in infectious diseases. This study aimed to evaluate the clinical efficacy of mNGS for diagnosing severe pneumonia.
Methods
This study retrospectively analyzed 323 patients with suspected severe pneumonia admitted to the intensive care unit (ICU) of Wuhan University Renmin Hospital between January 2022 and December 2023. Bronchoalveolar lavage fluid (BALF) samples were collected from all 323 patients, and blood samples were obtained from 80 patients. Both mNGS and conventional microbial testing (CMT) were performed on the collected BALF and blood samples to analyze the pathogen spectrum. The diagnostic performance of mNGS and CMT was systematically evaluated and compared.
Results
The overall positivity rate of mNGS was significantly greater than that of CMT (93.5% vs. 55.7%, p < 0.001). mNGS demonstrated significantly greater sensitivity than did CMT (94.74% vs. 57.24%, p < 0.001) but lower specificity (26.32% vs. 68.42%, p < 0.01). mNGS identified 36 bacterial species, 14 fungal species, 7 viral species, and 1 Chlamydia species, whereas CMT detected 21 bacterial species and 9 fungal species. According to the pathogen spectrum, Klebsiella pneumoniae, Acinetobacter baumannii, and Candida albicans were the predominant pathogens associated with severe pneumonia. The detection rate of mixed infections was significantly higher with mNGS than with CMT (62.8% vs. 18.3%, p < 0.001).
Conclusions
Compared with CMT methods, mNGS has significant advantages in pathogen detection for severe pneumonia. Owing to its broad detection range and high sensitivity, mNGS serves as a valuable complementary approach to traditional culture-based methods.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
- Department of Vascular Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
- Department of Urology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
- Department of Orthopedics, the Airborne Military Hospital, Wuhan, Hubei, China.
- Department of Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
- Department of Critical Care Medicine, Xianfeng County People's Hospital, Enshi, Hubei, China.
Zitieren
APA
Huang, R., Zhang, Y., Dong, C., Chen, J., Zou, H., Liu, Y., Guo, M., Gao, H., Ke, Q., & Wu, W. (2025). Clinical application of metagenomic next-generation sequencing in the diagnosis of severe pneumonia pathogens. Frontiers in Cellular and Infection Microbiology, 15. https://doi.org/10.3389/fcimb.2025.1661213
Vancouver
Huang R, Zhang Y, Dong C, Chen J, Zou H, Liu Y, et al. Clinical application of metagenomic next-generation sequencing in the diagnosis of severe pneumonia pathogens. Frontiers in Cellular and Infection Microbiology. 2025;15. doi:10.3389/fcimb.2025.1661213
BibTeX
@article{Huang2025,
author = {Huang, Raojuan and Zhang, Ying and Dong, Caitao and Chen, Jingdi and Zou, Handong and Liu, Yang and Guo, Mengmeng and Gao, Hang and Ke, Quan and Wu, Wei},
title = {Clinical application of metagenomic next-generation sequencing in the diagnosis of severe pneumonia pathogens},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
volume = {15},
doi = {10.3389/fcimb.2025.1661213}
}
EUVIMED